在全球范围内进行干预性肺病学
Kubra Melike Bozkanat1, Dirk Schramm2
1Department of Pediatrics, Division of Pulmonary, Asthma and Sleep, Stanford University School of Medicine, Palo Alto, California, USA.
Current opinion in pediatrics
|April 10, 2025
概括
儿科干预性肺病学 (PIP) 推进了儿童的呼吸护理,但全球采用面临挑战. 国际合作和标准化培训对于公平获得这些救命程序至关重要.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 干预性肺病学 干预性肺病学
- 医疗技术创新 医疗技术创新
背景情况:
- 儿科干预性肺病学 (PIP) 是一个快速发展的子专业,专注于使用程序干预来诊断和治疗儿科呼吸系统疾病.
- 该领域的目标是改善患有复杂呼吸道疾病,先天性异常和其他肺部问题的儿童的治疗结果.
- 全球采用PIP进步的情况不均,这带来了重大挑战.
研究的目的:
- 审查儿科干预性肺病学的最新技术发展.
- 讨论全球采用这些新的PIP技术的挑战和差异.
- 突出PIP在全球范围内改变儿科呼吸系统护理的潜力.
主要方法:
- 对儿科干预性肺病学的最新创新进行审查,包括冷探针,支气管镜和内支气管超声波.
- 分析这些技术在儿科呼吸道管理中的应用和局限性.
- 考察影响PIP全球实施的地理和经济因素.
主要成果:
- 像超薄冷探测器和先进的支气管镜这样的创新促进了儿科呼吸道诊断和干预.
- 低温疗法在活检,狭窄治疗和异物清除方面表现有前途;内支气管超声波有助于诊断,但面临着可访问性问题.
- 新兴的气管食道片修复和空气泄漏管理技术显示出潜力,但需要更多的证据;高收入国家和低收入/中等收入国家之间存在重大差异.
结论:
- 儿科干预性肺病学对儿科呼吸系统护理具有变革性的潜力.
- 全球领养率的巨大差异需要国际合作,标准化培训和资源分配.
- 虚拟培训平台和全球会议可以帮助弥合这些差距,促进公平的增长和改善患者的治疗结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
126
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
126
Other Pulmonary Disorders
786
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
786
COPD: Management Using Bronchodilators and Corticosteroids
144
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
144
Pulmonary Hypertension: Classification and Pathogenesis
120
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
120
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K


